Activating Compound | Comment | Organism | Structure |
---|---|---|---|
additional information | hypoxic treatment induces the protein expression of PGK 3fold, induction of HIF-1alpha by addition of 0.5 mM dimethyloxallyl glycine increases PGK expression under normoxic conditions | Homo sapiens |
Application | Comment | Organism |
---|---|---|
medicine | overexpression or down-regulation of PGK affects the cytotoxicity of beta-L-dioxolane-cytidine, which is under clinical trials for treating cancer, but not that of beta-D-2',2'-difluorodeoxycytidine under normoxic conditions, overexpression of PGK does not further increase the cytotoxicity of beta-L-dioxolane-cytidine under hypoxic conditions | Homo sapiens |
Cloned (Comment) | Organism |
---|---|
overexpression of PGK using transient transfection of pcDNA5-PGK | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
shRNA | knockdown of PGK, followed by a reduced cytotoxicity of beta-L-dioxolane-cytidine approximately 1.4- and 1.8fold under normoxic and hypoxic conditions, respectively | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
A-673 cell | hypoxic treatment induces the protein expression of PGK | Homo sapiens | - |
HEP-3B cell | - |
Homo sapiens | - |
HEP-3B cell | hypoxic treatment induces the protein expression of PGK | Homo sapiens | - |
Hep-G2 cell | - |
Homo sapiens | - |
Hep-G2 cell | hypoxic treatment induces the protein expression of PGK | Homo sapiens | - |
additional information | A-673 cell | Homo sapiens | - |
PANC-1 cell | - |
Homo sapiens | - |
PANC-1 cell | hypoxic treatment induces the protein expression of PGK | Homo sapiens | - |
RKO cell | - |
Homo sapiens | - |
RKO cell | hypoxic treatment induces the protein expression of PGK | Homo sapiens | - |
Synonyms | Comment | Organism |
---|---|---|
PGK | - |
Homo sapiens |